Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Bodies Respond To EU Ministers' Plans To Address 'Balance' In Pharmaceutical System

This article was originally published in SRA

Executive Summary

In response to news that the European Commission is to conduct an analysis of the effects of regulatory incentives such as data and market exclusivity on innovation, drug pricing, access to medicines and generic entry, two of the key pharmaceutical industry bodies, Medicines for Europe and EFPIA, have come up with their own proposals for engaging with the EU member states to ensure the long-term sustainability of national healthcare systems.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts